In a Healio Video Perspective from the American Psychiatric Association Annual Meeting, Dr. Randall F. White discusses the high prevalence of substance use disorders among patients with schizophrenia. He highlights the challenge of treating co-occurring stimulant use disorder and schizophrenia, as stimulants like methamphetamine can worsen psychosis. White stresses the importance of prioritizing treatment of psychosis until the patient is stable, at which point addressing the substance abuse disorder becomes the focus. It is crucial to assess and intervene for both disorders as soon as possible for effective treatment. White’s insights are based on a presentation he made at the APA Annual Meeting.
Source link
Co-occurring schizophrenia, stimulant use disorder ‘challenging’ to treat
